Cargando…
Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis
Background: Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive subtype of peripheral T-cell lymphoma (PTCL) that has a poor 5-year overall survival rate due to its lack of precise therapeutic targets. Identifying potential prognostic markers of AITL may provide information regarding the deve...
Autores principales: | Li, Xiaoqian, Liu, Zijian, Mi, Mi, Zhang, Caijiao, Xiao, Yin, Liu, Xinxiu, Wu, Gang, Zhang, Liling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559227/ https://www.ncbi.nlm.nih.gov/pubmed/31239775 http://dx.doi.org/10.2147/CMAR.S185030 |
Ejemplares similares
-
Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics
por: Liu, Zijian, et al.
Publicado: (2018) -
Successful Treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma With Evans Syndrome: A Case Report With Long-Term Follow-Up
por: Zhu, Fang, et al.
Publicado: (2020) -
Identification of Hub Genes and Key Pathways Associated with Follicular Lymphoma
por: Zhang, Qing, et al.
Publicado: (2022) -
Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study
por: Mi, Mi, et al.
Publicado: (2020) -
Hub genes and their key effects on prognosis of Burkitt lymphoma
por: Xu, Yan-Feng, et al.
Publicado: (2023)